Huo Haibo, Dan Wenjia, Li Min, Chen Yanbin, Yang Chaofu, Wu Lintao, Shi Baojun, Li Jian
Department of Life Sciences, Changzhi University, Changzhi, 046011, Shanxi, China.
School of Life Science and Technology, Weifang Medical University, Shandong, China.
Eur J Med Chem. 2025 Feb 5;283:117156. doi: 10.1016/j.ejmech.2024.117156. Epub 2024 Dec 10.
Rational modification of natural products plays a key role in drug discovery. Herein, a series of steroidal indole derivatives containing various substituents and steroidal skeletons were designed and synthesized with classical Fischer indole synthesis as a key step in an efficient synthetic route for the first time. The in vitro antibacterial activity of all the synthesized derivatives was evaluated against four Gram-positive strains including three Methicillin-Resistant Staphylococcus aureus. Compound 11e displayed the most potent antibacterial activity (MIC = 1-2 μg/mL) with low cytotoxicity and hemolytic activity. Derivative 11e displayed more rapid bactericidal kinetic than vancomycin in the time-kill study and was less likely to induce bacterial resistance. Moreover, the preliminary antibacterial mechanism explorations indicated that compound 11e could effectively inhibit biofilm formation, promote the accumulation of reactive oxygen species, decrease bacterial metabolism, and destroy bacterial cell membranes to exert its antibacterial effects. The study of in vivo antibacterial activity suggested that compound 11e could significantly reduce the bacteria counts in a mouse subcutaneous infection model. These findings provided a bright hope for steroidal indole derivatives as promising antibacterial candidates to settle drug resistance.
天然产物的合理修饰在药物发现中起着关键作用。在此,首次以经典的费歇尔吲哚合成作为关键步骤,设计并合成了一系列含有各种取代基和甾体骨架的甾体吲哚衍生物,该合成路线高效。评估了所有合成衍生物对包括三种耐甲氧西林金黄色葡萄球菌在内的四种革兰氏阳性菌株的体外抗菌活性。化合物11e表现出最有效的抗菌活性(MIC = 1-2μg/mL),且细胞毒性和溶血活性较低。在时间-杀菌研究中,衍生物11e的杀菌动力学比万古霉素更快,且不太可能诱导细菌耐药性。此外,初步的抗菌机制探索表明,化合物11e可有效抑制生物膜形成,促进活性氧的积累,降低细菌代谢,并破坏细菌细胞膜以发挥其抗菌作用。体内抗菌活性研究表明,化合物11e可显著降低小鼠皮下感染模型中的细菌数量。这些发现为甾体吲哚衍生物作为有前途的抗菌候选物解决耐药性问题带来了光明的希望。